Neurogene Inc
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neurogene Inc and other ETFs, options, and stocks.About NGNE
Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.
NGNE Key Statistics
Stock Snapshot
With a market cap of 263.48M, Neurogene Inc(NGNE) trades at $17.00. The stock has a price-to-earnings ratio of -3.84.
On 2026-02-13, Neurogene Inc(NGNE) stock opened at $17.00, reached a high of —, and a low of —.
Neurogene Inc(NGNE) shares are trading with a volume of 0, against a daily average of 119.62K.
During the past year, Neurogene Inc(NGNE) stock moved between $6.88 at its lowest and $37.27 at its peak.
During the past year, Neurogene Inc(NGNE) stock moved between $6.88 at its lowest and $37.27 at its peak.
Analyst ratings
100%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.